Dampening the downstream effects of a high concentration of α-defensins may render AAT and TLR4 inhibitors as potential therapies to decrease NTHi colonization and increase its clearance by phagocytosis in AATD individuals. This evidence concerns the gene TLR4 and alpha 1-antitrypsin deficiency.